![Madhu Cherukury](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Madhu Cherukury
Algemeen Directeur bij Allgenesis Biotherapeutics, Inc.
Actieve functies van Madhu Cherukury
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Allgenesis Biotherapeutics, Inc.
![]() Allgenesis Biotherapeutics, Inc. BiotechnologyHealth Technology Allgenesis Biotherapeutics, Inc. is a Taiwanese clinical-stage biopharmaceutical company focused on researching and developing novel medicines for the treatment of eye diseases. The private company is based in Taipei, Taiwan. The company's current pipeline includes potential blockbuster drugs such as ag-73305 for the treatment of DME, NAMD, and other retinal diseases, as well as ag-80308 for dry eye disease. The company was founded by Chih Lung Shen and Chih Ming Chen. Madhu Cherukury has been the CEO of the company since 2014. | Directeur/Bestuurslid | - | - |
Algemeen Directeur | 01-06-2018 | - |
Loopbaan van Madhu Cherukury
Statistieken
Internationaal
Taiwan | 2 |
Operationeel
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Sectoraal
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Allgenesis Biotherapeutics, Inc.
![]() Allgenesis Biotherapeutics, Inc. BiotechnologyHealth Technology Allgenesis Biotherapeutics, Inc. is a Taiwanese clinical-stage biopharmaceutical company focused on researching and developing novel medicines for the treatment of eye diseases. The private company is based in Taipei, Taiwan. The company's current pipeline includes potential blockbuster drugs such as ag-73305 for the treatment of DME, NAMD, and other retinal diseases, as well as ag-80308 for dry eye disease. The company was founded by Chih Lung Shen and Chih Ming Chen. Madhu Cherukury has been the CEO of the company since 2014. | Health Technology |
- Beurs
- Insiders
- Madhu Cherukury
- Ervaring